Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
December 21, 2022
The role of surveillance imaging for resected high-risk melanoma
Mabel K Yan, Nikki R Adler, Rory Wolfe, et al.
Clinical & Translational Immunology
|
September 11, 2023
Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma
Jack M Edwards, Miles C Andrews, Hayley Burridge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2020
Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial
Gishan Ratnayake, Simone Reinwald, Mark Shackleton, et al.
JCO Precision Oncology
|
June 7, 2024
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma
Miles C Andrews, Gerald Li, Ryon P Graf, et al.
Nature Communications
|
August 23, 2016
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Breast Cancer Research and Treatment
|
July 23, 2020
Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice
Genevieve V Dall, Jessica Vieusseux, Yashar Seyed-Razavi, et al.
Molecular Imaging and Biology
|
June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological Heterogeneity
Robert E Ware, Damien Kee, Peter Roselt, et al.
Clinical Lung Cancer
|
August 12, 2020
Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC
Evangeline Samuel, Gabrielle Lie, Adithya Balasubramanian, et al.
Cancer Immunity
|
September 24, 2004
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand
Mark Shackleton, Ian D Davis, Wendie Hopkins, et al.
JCO Precision Oncology
|
January 7, 2022
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model
Eryn Dow, Alison Freimund, Kortnye Smith, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Asia-Pacific Journal of Clinical Oncology
|
December 21, 2022
The role of surveillance imaging for resected high-risk melanoma
Mabel K Yan, Nikki R Adler, Rory Wolfe, et al.
Clinical & Translational Immunology
|
September 11, 2023
Design, optimisation and standardisation of a high-dimensional spectral flow cytometry workflow assessing T-cell immunophenotype in patients with melanoma
Jack M Edwards, Miles C Andrews, Hayley Burridge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 26, 2020
Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial
Gishan Ratnayake, Simone Reinwald, Mark Shackleton, et al.
JCO Precision Oncology
|
June 7, 2024
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma
Miles C Andrews, Gerald Li, Ryon P Graf, et al.
Nature Communications
|
August 23, 2016
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Ugur Eskiocak, Vijayashree Ramesh, Jennifer G Gill, et al.
Breast Cancer Research and Treatment
|
July 23, 2020
Parity reduces mammary repopulating activity but does not affect mammary stem cells defined as CD24 + CD29/CD49fhi in mice
Genevieve V Dall, Jessica Vieusseux, Yashar Seyed-Razavi, et al.
Molecular Imaging and Biology
|
June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological Heterogeneity
Robert E Ware, Damien Kee, Peter Roselt, et al.
Clinical Lung Cancer
|
August 12, 2020
Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC
Evangeline Samuel, Gabrielle Lie, Adithya Balasubramanian, et al.
Cancer Immunity
|
September 24, 2004
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand
Mark Shackleton, Ian D Davis, Wendie Hopkins, et al.
JCO Precision Oncology
|
January 7, 2022
Cancer Diagnoses Following Abnormal Noninvasive Prenatal Testing: A Case Series, Literature Review, and Proposed Management Model
Eryn Dow, Alison Freimund, Kortnye Smith, et al.
Page
of 10